Clinical Trials Logo

Clinical Trial Summary

To confirm the effectiveness and safety of the transcatheter mitral valve repair system for the treatment of chronic moderate to severe (3+) or severe (4+) functional mitral regurgitation (FMR) who remained clinically symptomatic after guideline-directed medical treatment.


Clinical Trial Description

This study is a prospective, multicenter, objective performance criteria clinical design.Patients are moderate to severe (3+) or severe (4+) functional mitral regurgitation (FMR) who remained clinically symptomatic after guideline-directed medical treatment. All subjects receive clinical follow-up immediately after procedure, before discharge, 30 days after procedure, 6 months after transfemoral mitral-valve repair, 12 months and 2 yeas,3 years,4 years after Transfemoral mitral-valve repair. The primary outcome is defined as all-cause death and rehospitalization due to heart failure 12 months after Transfemoral mitral-valve repair. The secondary outcomes include:Rate of rehospitalization due to heart failure after operation;Rate of postoperative mitral regurgitation (MR ≤ 2+);Rate of New York Heart Association (NYHA) Function Class I or II after Transfemoral mitral-valve repair;Change in 6 minutes walk test distance;Improvement value of quality of life changes assessed by Kansas City Cardiomyopathy Questionnaire (KCCQ);Echocardiographic changes in left ventricular end diastolic volume (LVEDV) from baseline;Acute procedural success,Acute device success. ;


Study Design


Related Conditions & MeSH terms


NCT number NCT05508438
Study type Interventional
Source Chinese Academy of Medical Sciences, Fuwai Hospital
Contact Yueyan li
Phone +86 15189109112
Email yyli@kokalife.com
Status Not yet recruiting
Phase N/A
Start date August 30, 2022
Completion date December 30, 2027

See also
  Status Clinical Trial Phase
Recruiting NCT03962023 - Prognostic Impact of Imaging Parameters in Patients With Primary Mitral Insufficiency by Prolapse (COHORTE-IM)
Withdrawn NCT02624960 - Safety and Performance of the AccuCinch® System N/A
Terminated NCT02428010 - Twelve Transcatheter Mitral Valve Replacement (TMVR) Pilot Study N/A
Active, not recruiting NCT01533883 - Cardioband Adjustable Annuloplasty System for Minimally Invasive Mitral Valve Repair N/A
Unknown status NCT01201070 - Study of Administration Of Antithrombin in Patients With Low Plasmatic Levels of Antithrombin After Cardiac Surgery Phase 4
Terminated NCT00700947 - Using Beta Blockers to Treat Mitral Regurgitation Phase 1
Completed NCT04351984 - Transcatheter Mitral Valvuloplasty Pilot Study
Completed NCT04231331 - Ertugliflozin for Functional Mitral Regurgitation Phase 3
Completed NCT05742789 - Effect of Anesthetics on Troponin I and С-reactive Protein Phase 1
Recruiting NCT02803957 - Randomized Trial of the Neochord DS1000 System Versus Open Surgical Repair N/A
Recruiting NCT04153292 - The ENCIRCLE Trial N/A
Completed NCT02607527 - Annular Reshaping of the Mitral Valve for Patients With Mitral Regurgitation Using the Millipede IRIS System N/A
Active, not recruiting NCT03066050 - Long Term Follow Up for CTSN Mitral Valve Repair Studies
Active, not recruiting NCT04443218 - Edwards PASCAL Transcatheter Valve Repair System Registry
Enrolling by invitation NCT04067635 - Primary Mitral Regurgitation Repair
Completed NCT01966146 - Examination of Valve Insufficiency Before and After MitraClip or TAVI Procedure by 3D Echocardiography Compared to MRI N/A
Recruiting NCT01368575 - Surgical Treatment of Ischemic Mitral Regurgitation Phase 4
Completed NCT00001314 - Investigation of Heart Function in Patients With Heart Valve Defects N/A
Terminated NCT03285724 - Safety and Performance Study of the Harpoon Mitral Valve Repair System N/A
Withdrawn NCT04709042 - Acquisition of Objective Data During Transapical Neochordae Implantation N/A